• No results found

[PDF] Top 20 Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation.

Has 10000 "Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation." found on our website. Below are the top 20 most common "Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation.".

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation.

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation.

... 587 patients included in this study, 233 (39.7 %) patients were female with a mean age of ...median survival time of patients was 517 days (Range: 7 - 5672 ...of cGVHD was 7, ...months ... See full document

10

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

... blood stem cells (PBSC) to favor engraftment and enhance the graft-versus-leukemia (GVL) effect [11, ...T cell depletion with anti-thymocyte globulin (ATG) reduces the incidence of cGVHD ... See full document

11

Original Article Impact of pre-transplant bone marrow blast percentage on survival in acute myeloid leukemia patients

Original Article Impact of pre-transplant bone marrow blast percentage on survival in acute myeloid leukemia patients

... Objectives: Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the most effective treatment for most of the patients with acute myeloid leukemia ... See full document

7

Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia.

Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia.

... in patients who have relapsed after allo-SCT for AML or MDS. Patients with active acute or chronic GVHD or a history of grade 3 or 4 GVHD were ex- ...ltration rate less than or equal to ... See full document

14

<p>Assessment of the presence and anti-tumor potential of tumor-infiltrating lymphocytes in patients with acute myeloid leukemia</p>

<p>Assessment of the presence and anti-tumor potential of tumor-infiltrating lymphocytes in patients with acute myeloid leukemia</p>

... Acute myeloid leukemia (AML) is the most common hematological malignancies in adults, with an incidence rate ranging from three to fi ve cases per 1,00,000 ...abnormal myeloid ... See full document

10

&lt;p&gt;High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation&lt;/p&gt;

<p>High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation</p>

... overall survival (OS), which was de fi ned as the time from diagnosis to death or was censored at the last ...OS rate was calculated using the Kaplan – Meier method, and the survival curves were ... See full document

8

&lt;p&gt;Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Ho

<p>Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease</p>

... hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment for intermedi- ate/high-risk MDS and acute myeloid leukemia ...poietic stem cell ... See full document

9

Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China

Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China

... that patients who receive haploidentical HSCT experience significantly delayed myeloid and platelet recoveries compared with those re- ceiving HLA-matched HSCT [14, ...the patients who received ... See full document

10

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

... hematopoietic cell transplantation (HCT) in acute myelogenous leukemia (AML) remains ...AML patients treated with oral busulfan (1 mg/kg every 6 hours for 4 days) and cyclophosphamide ... See full document

9

Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

... similar patients from the International Bone Marrow Transplant Registry, the hazard of mortality of antibody- treated patients was ...older patients with advanced AML or high risk ...relapse ... See full document

25

Original Article Survival disparities in patients with relapsed core-binding factor acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

Original Article Survival disparities in patients with relapsed core-binding factor acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

... factor acute myeloid leukemia (CBF-AML) has traditionally been associated with favorable prognosis ...of allogeneic hematopoietic stem cell transplantation (HSCT) in first ... See full document

9

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party

... of acute and chronic GVHD, NRM, and disease relapse incidence ...as survival without relapse or progression and NRM as death with- out ...II–IV acute GVHD rate and Cox proportional hazards ... See full document

14

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report

... prolonged survival with reduced weight loss and GvHD severity by histology studies and suppression of the serum inflammatory cytokine ...SR-GVHD—54 acute and 51 chronic GvHD (cGvHD), reported the ... See full document

5

Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia

Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia

... ALL: Acute lymphoid leukemia; allo- HSCT: Allogeneic hematopoietic stem cell transplantation; AML: Acute myeloid leukemia; ANC: Absolute neutrophil count; ... See full document

11

Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor

Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor

... AML patients with trisomy 10 and their impact in disease progression and prognosis remains unclear ...cases, patients with a history of MDS and patients with a pro- gressive clinical course of ... See full document

7

Clinical use of FLT3 inhibitors in acute myeloid leukemia

Clinical use of FLT3 inhibitors in acute myeloid leukemia

... confer survival advantage, and activation of STAT5 may lead to genomic instability through generation of reactive oxygen species and subsequent double-strand DNA breakage, both of which may be associated with poor ... See full document

12

Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011

Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011

... chronic myeloid leukemia in n = 11 patients (Figure 1). For acute lympho- blastic leukemia, n = 4 were positive for Philadelphia chromosome, n = 3 had disease ...Three patients ... See full document

7

Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta analysis with trial sequential analysis

Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta analysis with trial sequential analysis

... We evaluated the exposure–response relationship be- tween posaconazole plasma concentration and clinical efficacy for IFIs prevention. When the plasmas were measured at different sampling time, we chose the re- sults ... See full document

13

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

... Chang et al. focused on the relationship between donor-specific anti-HLA antibodies (DSAs) and primary graft failure (GF) after HID-HSCT and designed a prospective study with randomly assigned training and ... See full document

17

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

... decreased rate of grade III– IV aGvHD and total chronic GVHD in the ATG-PTCy cohort compared to control cohort, the incidence for moderate to severe chronic GVHD remains ...the rate of moderate to ... See full document

9

Show all 10000 documents...